JP2017531678A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531678A5
JP2017531678A5 JP2017522086A JP2017522086A JP2017531678A5 JP 2017531678 A5 JP2017531678 A5 JP 2017531678A5 JP 2017522086 A JP2017522086 A JP 2017522086A JP 2017522086 A JP2017522086 A JP 2017522086A JP 2017531678 A5 JP2017531678 A5 JP 2017531678A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
groups
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017522086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017531678A (ja
JP6616412B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/074431 external-priority patent/WO2016062790A1/en
Publication of JP2017531678A publication Critical patent/JP2017531678A/ja
Publication of JP2017531678A5 publication Critical patent/JP2017531678A5/ja
Application granted granted Critical
Publication of JP6616412B2 publication Critical patent/JP6616412B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017522086A 2014-10-23 2015-10-22 Nik阻害剤としての新規のピラゾロピリミジン誘導体 Expired - Fee Related JP6616412B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14190073.8 2014-10-23
EP14190073 2014-10-23
PCT/EP2015/074431 WO2016062790A1 (en) 2014-10-23 2015-10-22 New pyrazolopyrimidine derivatives as nik inhibitors

Publications (3)

Publication Number Publication Date
JP2017531678A JP2017531678A (ja) 2017-10-26
JP2017531678A5 true JP2017531678A5 (enExample) 2019-11-21
JP6616412B2 JP6616412B2 (ja) 2019-12-04

Family

ID=51846471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017522086A Expired - Fee Related JP6616412B2 (ja) 2014-10-23 2015-10-22 Nik阻害剤としての新規のピラゾロピリミジン誘導体

Country Status (13)

Country Link
US (2) US10221180B2 (enExample)
EP (1) EP3209663B1 (enExample)
JP (1) JP6616412B2 (enExample)
KR (1) KR102523405B1 (enExample)
CN (1) CN107074882B (enExample)
AU (1) AU2015334915B2 (enExample)
BR (1) BR112017007704B1 (enExample)
CA (1) CA2960574C (enExample)
EA (1) EA033237B1 (enExample)
ES (1) ES2715104T3 (enExample)
IL (1) IL251778B (enExample)
MX (1) MX371152B (enExample)
WO (1) WO2016062790A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
WO2016062789A1 (en) 2014-10-23 2016-04-28 Janssen Pharmaceutica Nv New thienopyrimidine derivatives as nik inhibitors
WO2016062790A1 (en) 2014-10-23 2016-04-28 Janssen Pharmaceutica Nv New pyrazolopyrimidine derivatives as nik inhibitors
JP6676048B2 (ja) 2014-10-23 2020-04-08 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規化合物
MX371150B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv NUEVOS DERIVADOS DE PIRAZOL EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).
EP3801499B1 (en) 2018-06-07 2024-02-28 Disarm Therapeutics, Inc. Inhibitors of sarm1
EA202092962A1 (ru) * 2018-06-18 2021-09-06 Янссен Фармацевтика Нв Производные пиразола в качестве ингибиторов malt1
EP3897670A4 (en) 2018-12-19 2022-09-07 Disarm Therapeutics, Inc. MRSA1 INHIBITORS IN COMBINATION WITH NEUROPROTECTIVE AGENTS
CA3134937A1 (en) * 2019-03-29 2020-10-08 Kowa Company, Ltd. Novel azaindole derivative
PH12021553011A1 (en) 2019-05-31 2022-11-07 Janssen Pharmaceutica Nv SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX19185A (es) * 1989-01-20 1993-12-01 Pfizer Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
BRPI0510319A (pt) 2004-04-26 2007-10-16 Pfizer inibidores da enzima integrase de hiv
TW200736260A (en) 2005-11-10 2007-10-01 Smithkline Beecham Corp Inhibitors of Akt activity
DE102008005493A1 (de) 2008-01-22 2009-07-23 Merck Patent Gmbh 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
WO2009158011A1 (en) * 2008-06-26 2009-12-30 Amgen Inc. Alkynyl alcohols as kinase inhibitors
US20110201599A1 (en) 2008-07-03 2011-08-18 Exelixis, Inc. CDK Modulators
WO2010042337A1 (en) 2008-10-07 2010-04-15 Merck Sharp & Dohme Corp. Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
CN101723936B (zh) 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
WO2011050245A1 (en) 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
CA2827161A1 (en) 2011-03-16 2012-09-20 F. Hoffmann-La Roche Ag 6,5-heterocyclic propargylic alcohol compounds and uses therefor
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
WO2016062790A1 (en) 2014-10-23 2016-04-28 Janssen Pharmaceutica Nv New pyrazolopyrimidine derivatives as nik inhibitors
WO2016062789A1 (en) 2014-10-23 2016-04-28 Janssen Pharmaceutica Nv New thienopyrimidine derivatives as nik inhibitors
JP6676048B2 (ja) 2014-10-23 2020-04-08 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規化合物
MX371150B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv NUEVOS DERIVADOS DE PIRAZOL EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).

Similar Documents

Publication Publication Date Title
JP2017531678A5 (enExample)
JP2017531677A5 (enExample)
AU2014233414B2 (en) N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
JP2016531868A5 (enExample)
JP2019094345A5 (enExample)
US20170157134A1 (en) Combination therapy
JP2019524883A5 (enExample)
JP2016537366A5 (enExample)
JP2010524932A5 (enExample)
JP2016531858A5 (enExample)
JP2014037426A5 (enExample)
JP2012510458A5 (enExample)
JP2015503540A5 (enExample)
JP2013522229A5 (enExample)
JP2019515884A5 (enExample)
WO2009082818A8 (en) Novel c-21-keto lupane derivatives preparation and use thereof
JP2014506582A5 (enExample)
RU2018113718A (ru) Новые соединения
MX2021006544A (es) Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer.
JP2019505529A5 (enExample)
JP2019535723A5 (enExample)
RU2012130929A (ru) Гетероциклические соединения в качестве ингибиторов янус-киназы
JP2024507414A (ja) ウイルス感染症治療のためのrock2阻害剤
RU2007103831A (ru) Производные пиразола
MX2010013978A (es) Derivados de 5-(4-metanosulfonilfenil)tiazol para el tratamiento de enfermedades inflamatorias agudas y cronicas.